Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia
NCT ID: NCT01909336
Last Updated: 2016-12-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
161 participants
INTERVENTIONAL
2013-07-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to determine if isotonic solutions reduce the risk of hospital acquired hyponatremia compared with hypotonic solutions
This study will include 150 patients in 2 groups according to these type of pathology: group 1: medical conditions which includes respiratory problems (pneumonia, bronchiolitis, acute asthma attack) and acute gastrointestinal problems (bacterial or viral gastroenteritis) and group 2: surgical conditions (pre, peri or postoperative patients will be included). Each group will be randomized to receive 3 types of interventions: 0.3% Saline (hypotonic solution), 0.45% Saline (hypotonic solution) or 0.9% Saline (isotonic solution). In non-dehydrated patients the daily total volume of liquid infused will be determined by the volumetric Holliday- Segar\* formula and the daily total volume will be calculated by adding the maintenance requirements (using the Holliday Segar formula) to the fluid deficit (according to percent of estimated weight\*\*) in dehydrated patients.
The glucose concentrations in the first group will be 3.3%, and in group 2 and 3 will be 5%. The potassium concentration will be 20mEq/L in all groups. Blood samples will be collected before, 8 hours and 24 hours after the start of intravenous fluid, for the analysis of sodium, potassium, glucose, urea and creatinine. The adverse clinical outcomes at 8 and 24 hours of the start of intravenous fluid will also be recorded. The sodium plasma level, the incidence of hyponatremia and the adverse clinical outcomes will be compared.
\*0-10 kilogram (kg): 100ml/kg per day; 10-20 kg: 1000 ml + 50 ml/kg/day over 10 kg; \>20 kg: 1500 ml + 20ml/ kg over 20kg
\*\* In patients under 10 kg correspond to a loss of 5% (50 mL/kg) in mild dehydration and 10% in moderate dehydration. In 10 kg or more: 3% (30 mL/kg) in mild dehydration and 6% (60 mL/kg) in moderate dehydration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: 0.3% Saline in 3.3% dextrose (intravenous)
Group 1: 0.3% Saline in 3.3% dextrose (intravenous)
0.3% Saline in 3.3% dextrose
Hypotonic Solutions: 0.3% Saline in 3.3% dextrose
Group 2: 0.45% Saline in 5% dextrose (intravenous)
Group 2: 0.45% Saline in 5% dextrose (intravenous)
0.45% Saline in 5% dextrose
Hypotonic Solutions: 0.45% Saline in 5% dextrose
Group 3: 0.9% Saline in 5% dextrose (intravenous)
Group 3: 0.9% Saline in 5% dextrose (intravenous)
0.9% Saline in 5% dextrose
Isotonic Solutions 0.9% Saline in 5% dextrose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.3% Saline in 3.3% dextrose
Hypotonic Solutions: 0.3% Saline in 3.3% dextrose
0.45% Saline in 5% dextrose
Hypotonic Solutions: 0.45% Saline in 5% dextrose
0.9% Saline in 5% dextrose
Isotonic Solutions 0.9% Saline in 5% dextrose
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Need for intravenous fluids for 8 hours or more.
* Normal serum sodium at the beginning of the study of the study (135-145 mEQ/L).
* Acute respiratory problems (acute asthma attack, bronchiolitis or pneumonia).
* Acute gastrointestinal disorders (viral o bacterial gastroenteritis).
* Elective surgical procedures.
* Pre, peri o post operative patients (acute appendicitis, intussusception, intestinal perforation, ileus).
Exclusion Criteria
* Severe hypernatremia (serum sodium \>155 mEq/L).
* Need for intravenous fluids for less than 8 hours according with their treating physician.
* Severe dehydration or Shock.
* Preexisting chronic diseases (renal diseases, heart diseases or endocrine disorders).
* Neurologic diseases.
* Head trauma.
* Cerebral edema or Intracranial hypertension.
* Diabetic ketoacidosis.
* Use of diuretics one week or less before the study.
* Need for admission to the pediatric critical intensive care unit
3 Months
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tecnologico de Monterrey
OTHER
Instituto Tecnologico y de Estudios Superiores de Monterey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Montserrat Flores Robles, MD
Claudia Montserrat Flores Robles
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Montserrat Flores Robles, MD
Role: PRINCIPAL_INVESTIGATOR
Tecnologico de Monterrey
Carlos Alberto Cuello García, MD
Role: STUDY_DIRECTOR
Centro de Medicina Basada en Evidencias, Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey.
References
Explore related publications, articles, or registry entries linked to this study.
Moritz ML, Ayus JC. Hospital-acquired hyponatremia--why are hypotonic parenteral fluids still being used? Nat Clin Pract Nephrol. 2007 Jul;3(7):374-82. doi: 10.1038/ncpneph0526.
Choong K, Kho ME, Menon K, Bohn D. Hypotonic versus isotonic saline in hospitalised children: a systematic review. Arch Dis Child. 2006 Oct;91(10):828-35. doi: 10.1136/adc.2005.088690. Epub 2006 Jun 5.
Montanana PA, Modesto i Alapont V, Ocon AP, Lopez PO, Lopez Prats JL, Toledo Parreno JD. The use of isotonic fluid as maintenance therapy prevents iatrogenic hyponatremia in pediatrics: a randomized, controlled open study. Pediatr Crit Care Med. 2008 Nov;9(6):589-97. doi: 10.1097/PCC.0b013e31818d3192.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIvsSHnh
Identifier Type: -
Identifier Source: org_study_id